Image5_Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.TIF by Qi Wang (22418)

“…We carried out a random effect meta-analysis using RevMan 5.3. …”

Image9_Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.TIF by Qi Wang (22418)

“…We carried out a random effect meta-analysis using RevMan 5.3. …”

Table1_Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.docx by Qi Wang (22418)

“…We carried out a random effect meta-analysis using RevMan 5.3. …”

Image4_Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.TIF by Qi Wang (22418)

“…We carried out a random effect meta-analysis using RevMan 5.3. …”

Image10_Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.TIF by Qi Wang (22418)

“…We carried out a random effect meta-analysis using RevMan 5.3. …”

Image6_Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.TIF by Qi Wang (22418)

“…We carried out a random effect meta-analysis using RevMan 5.3. …”

Table4_Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.docx by Qi Wang (22418)

“…We carried out a random effect meta-analysis using RevMan 5.3. …”

Image8_Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.TIF by Qi Wang (22418)

“…We carried out a random effect meta-analysis using RevMan 5.3. …”

Image2_Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.TIF by Qi Wang (22418)

“…We carried out a random effect meta-analysis using RevMan 5.3. …”

Table3_Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.docx by Qi Wang (22418)

“…We carried out a random effect meta-analysis using RevMan 5.3. …”

Table5_Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.docx by Qi Wang (22418)

“…We carried out a random effect meta-analysis using RevMan 5.3. …”

Image11_Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.TIF by Qi Wang (22418)

“…We carried out a random effect meta-analysis using RevMan 5.3. …”

Gene Mutation in MicroRNA Target Sites of CFTR Gene: A Novel Pathogenetic Mechanism in Cystic Fibrosis? by Felice Amato (394509)

“…We identified three SNPs, one of which, the c.*1043A>C, was located in a region predicted to bind miR-433 and miR-509-3p. …”

Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates by Kristina Hacker (773425)

“…<div><p>The importance of the organic cation transporter OCT2 in the renal excretion of cationic drugs raises the possibility of drug-drug interactions (DDIs) in which an inhibitor (perpetrator) drug decreases OCT2-dependent renal clearance of a victim (substrate) drug. …”

Policy attention to climate change impacts, adaptation and vulnerability: a global assessment of National Communications (1994–2019) by Robbert Biesbroek (5906696)

“…Based on 612 documents, we find impact topics dominate policy attention (>50% of the topics), but this has decreased in recent periods. …”

Dynamics of soluble <i>Fgfr2b</i> expression and impact on AER maintenance after a single Dox-IP injection. by Soula Danopoulos (346564)

“…<p>(<b>A</b>) Embryos were collected at 0.5, 1,2,4,6,12 and 24 hrs after Dox IP at E11. …”

Image_2_Preoperative nTMS and Intraoperative Neurophysiology - A Comparative Analysis in Patients With Motor-Eloquent Glioma.tiff by Tizian Rosenstock (10837449)

“…Irreversible MEP amplitude decrease >50% was associated with worse motor outcome in all patients, while a MEP amplitude decrease ≤50% or lower SCS intensities ≤4mA were particularly correlated with a postoperative worsened motor status in nTMS-stratified high-risk cases. …”

Image_1_Preoperative nTMS and Intraoperative Neurophysiology - A Comparative Analysis in Patients With Motor-Eloquent Glioma.tiff by Tizian Rosenstock (10837449)

“…Irreversible MEP amplitude decrease >50% was associated with worse motor outcome in all patients, while a MEP amplitude decrease ≤50% or lower SCS intensities ≤4mA were particularly correlated with a postoperative worsened motor status in nTMS-stratified high-risk cases. …”

Table 5_The nature and extent of migrants, immigrants, and refugees' trust in the social institutions of their host countries: a scoping review.xlsx by Helena Godinho Nascimento (22335772)

Measuring malaria morbidity in an area of seasonal transmission: Pyrogenic parasitemia thresholds based on a 20-year follow-up study by Marion Dollat (6889490)